Metabolomics (Non-Targeted) of Induced Type 2 Diabetic Sprague Dawley Rats Comorbid with a Tissue-Dwelling Nematode Parasite.
Innocent Siyanda NdlovuSelaelo Ivy TshilwanePhilile Ignecious NgcamphalalaAndre' VoslooMamohale ChaisiSamson MukaratirwaPublished in: International journal of molecular sciences (2023)
Type 2 diabetes is a non-communicable metabolic syndrome that is characterized by the dysfunction of pancreatic β-cells and insulin resistance. Both animal and human studies have been conducted, demonstrating that helminth infections are associated with a decreased prevalence of type 2 diabetes mellitus (T2DM). However, there is a paucity of information on the impact that helminths have on the metabolome of the host and how the infection ameliorates T2DM or its progression. Therefore, this study aimed at using a non-targeted metabolomics approach to systematically identify differentiating metabolites from serum samples of T2DM-induced Sprague Dawley (SD) rats infected with a tissue-dwelling nematode, Trichinella zimbabwensis , and determine the metabolic pathways impacted during comorbidity. Forty-five male SD rats with a body weight between 160 g and 180 g were used, and these were randomly selected into control (non-diabetic and not infected with T. zimbabwensis ) (n = 15) and T2DM rats infected with T. zimbabwensis (TzDM) (n = 30). The results showed metabolic separation between the two groups, where d-mannitol, d-fructose, and glucose were upregulated in the TzDM group, when compared to the control group. L-tyrosine, glycine, diglycerol, L-lysine, and L-hydroxyproline were downregulated in the TzDM group when compared to the control group. Metabolic pathways which were highly impacted in the TzDM group include biotin metabolism, carnitine synthesis, and lactose degradation. We conclude from our study that infecting T2DM rats with a tissue-dwelling nematode, T. zimbabwensis , causes a shift in the metabolome, causing changes in different metabolic pathways. Additionally, the infection showed the potential to regulate or improve diabetes complications by causing a decrease in the amino acid concentration that results in metabolic syndrome.
Keyphrases
- type diabetes
- glycemic control
- metabolic syndrome
- insulin resistance
- body weight
- endothelial cells
- amino acid
- cardiovascular disease
- blood glucose
- diabetic rats
- high glucose
- oxidative stress
- mass spectrometry
- risk factors
- healthcare
- ms ms
- uric acid
- computed tomography
- high fat diet
- adipose tissue
- induced apoptosis
- magnetic resonance
- cancer therapy
- drug induced
- cell death
- risk assessment
- cell proliferation
- cell cycle arrest
- signaling pathway
- cardiovascular risk factors
- weight loss
- human health